Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225745 · ClinicalTrials.gov registry record
Ghrelin Levels in Pancreatic Cancer Patients
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 72
- Enrollment target
NCT00225745: Completed study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT00225745 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00225745 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The primary outcome measure for this study is plasma ghrelin level.
Interventions
- PROCEDURE Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2004-04 |
| Est. Completion | 2015-09 |
What the finished NCT00225745 record still lists
NCT00225745 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT00225745 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00225745 about?
NCT00225745 is a clinical study titled "Ghrelin Levels in Pancreatic Cancer Patients". The primary outcome measure for this study is plasma ghrelin level.
What is the current status of trial NCT00225745?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2004-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT00225745?
The interventions under investigation include: Blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00225745?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia